Prot# DFA104: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Efficacy and Safety of Pramlintide+Metreleptin in Obese Subjects Following a Low-Calorie Diet Lead-In

Project: Research project

Project Details

StatusFinished
Effective start/end date1/7/11 → 1/7/14

Funding

  • Medpace, Inc. (DFA104 // DFA104)
  • Amylin Pharmaceuticals, Inc. (DFA104 // DFA104)